< Back to all clusters
[HEALTH] · France · 3 sources

Alzheimer's research sees major diagnostic advances in France

Maxime Molina, President of the Board of Directors of the Foundation for Medical Research, reports major advancements in Alzheimer's disease research, particularly regarding diagnosis and prevention. With over 900,000 people affected by the disease in France, researchers have achieved a breakthrough in early detection using non-invasive blood tests. This allows for earlier patient management through non-medicinal solutions and easier integration into clinical trials.

While a cure does not yet exist, research has improved the understanding of the disease's causes, including genetic factors which account for 60% to 80% of cases, as well as environmental and infectious factors. Currently, specific Alzheimer's medications are not available on the French market because their benefit-to-risk ratio is deemed insufficient, despite showing efficacy in a very small number of specific patients.

Entities

Foundation for Medical Research · France · Maxime Molina

Claims

What the coverage asserts, and how many sources carry each claim.